Euclidean Technologies Management’s Moderna MRNA Stock Holding History

Euclidean Technologies Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$224K	Buy
2022 Q2	–	Sell
2022 Q1	$215K	Buy